The Autism Commission on Quality (ACQ) announced today that the accreditation agency will be offering two webinar sessions highlighting the new Applied Behavior Analysis (ABA) Accreditation Program Standards and Guide, version 1.0 – along with key elements of the accreditation review process. The complimentary webinars entitled, Accreditation with the Autism Commission on Quality, will provide an overview of ACQ’s:
• Standards development process
• ABA Standards and Guide
• Accreditation review process
RadSite™, a leading accrediting organization promoting performance and quality-based imaging practices, is announcing the first of its fall webinar series focusing on emerging CT trends. The complimentary webinar series will identify and discuss trends that impact advanced diagnostic imaging, including CT, MRI, and Nuclear Medicine (including SPECT/PET). The roundtable format will provide a strong interactive experience, allowing audience members to ask questions of the panel experts and gain their direct insights.
The Autism Commission on Quality (ACQ) announced today that it is launching its new accreditation program for provider organizations offering applied behavior analysis services to individuals with autism spectrum disorders. After a year of standards development, a public comment period, and a beta test cycle, the Applied Behavior Analysis Accreditation Program is now open to accept applications.
RadSite™, a leading accrediting organization promoting performance and quality-based imaging practices, announced today its fall webinar series. The focus of the series is key trends that impact advanced diagnostic imaging, including CT, MRI, and Nuclear Medicine (including SPECT/PET). The webinars feature experts in round table discussions to provide a more interactive experience, which will include taking questions from the audience.
RadSite™, a leading accrediting organization promoting performance and quality-based imaging practices, is announcing its fall webinar series discussing key Cone Beam CT imaging trends. The webinars feature experts in round table discussions to provide a more interactive experience, which will include taking questions from the audience.
The Autism Commission on Quality (ACQ) announces today the appointment of Erick Dubuque, Ph.D., BCBA-D, LBA as the nonprofit accreditation organization’s first Director. Dr. Dubuque was originally hired by the Council of Autism Service Providers (CASP) in 2021 to lead the establishment of ACQ, which launched in May.
The Autism Commission on Quality (ACQ), a non-profit accreditation organization for applied behavior analysis (ABA) organizations serving individuals and families impacted by autism, announced today that it is seeking nominations for its Standards, Accreditation, and Appeals Committees.
The Autism Commission on Quality (ACQ) has launched a new website, autismcommission.org. The website will offer an array of updates related to ACQ’s new accreditation program for applied behavior analysis organizations serving individuals with autism.
The Case Management Society of America (CMSA), a non-profit organization dedicated to the support and development of the profession of case management, and Schooner Strategies, a national consulting firm have teamed up to sponsor the 2022 version of the health information technology survey focusing on medical management systems. The initial results of the survey will be discussed at the CMSA Annual meeting on June 3, 2022 in Orlando, Florida.
The Center for Genomic Interpretation (CGI) continues hosting its cutting-edge Rising Tide Podcast series, which features nationally-recognized experts in precision medicine. In Episode 5, the CGI Podcast features an interview with Bryan Gall, PhD, a leading Clinical Variant Scientist in the germline clinical genetic test sector. The hour-long session, entitled “Variant Interpretation – the Achilles Heel of Clinical Genetics and Genomics: A conversation with a Clinical Variant Curation Team Supervisor working in the clinical genomic testing space,” focuses on some of the challenges and opportunities associated with ensuring the accurate interpretation of a genetic/genomic test results.